Galen Growth, which offers deep-dive digital-health market intelligence via HealthTech Alpha, announced that All Health Tech will serve as its sole authorised sales partner for India.

HealthTech Alpha is described as the industry’s “leading intelligence platform” for researching healthtech ventures, monitoring innovation trends, and performing competitive analysis. It aggregates vast data on startups, corporate partnerships, investment flows, regulatory events, clinical studies and product launches  enabling comprehensive insight into the global digital-health ecosystem. 

Through the exclusive agreement, All Health Tech will handle all commercial operations for the platform in India  including sales, onboarding, client support and custom deployment. This effectively brings HealthTech Alpha’s global-scale analytics and benchmarking capabilities into reach of Indian pharma, medtech, insurers, investment firms and policy planners. 

According to leadership statements, Galen Growth’s CEO highlighted India as “one of the most dynamic and fast-growing digital health markets globally,” and said the partnership deepens their commitment to support local stakeholders with world-class research tools. On his part, the founder of All Health Tech described the move as aligned with their mission to strengthen India’s health-tech ecosystem  equipping organisations with global-standard analytics, intelligence and AI-powered research capabilities.